Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CHRS - Coherus BioSciences, Inc.
145 M
LAST VALUE
74.50%
2 YEAR CAGR
162.13%
5 YEAR CAGR
81.59%
10 YEAR CAGR